These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 15087103)

  • 1. Levetiracetam in the treatment of Lennox-Gastaut syndrome.
    De Los Reyes EC; Sharp GB; Williams JP; Hale SE
    Pediatr Neurol; 2004 Apr; 30(4):254-6. PubMed ID: 15087103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome.
    Kim HJ; Kim SH; Kang HC; Lee JS; Chung HJ; Kim HD
    Pediatr Neurol; 2014 Oct; 51(4):527-31. PubMed ID: 25266616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
    Brodtkorb E; Klees TM; Nakken KO; Lossius R; Johannessen SI
    Epilepsy Behav; 2004 Apr; 5(2):231-5. PubMed ID: 15123025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.
    Caraballo RH; Cersósimo R; De los Santos C
    Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case.
    Díaz Negrillo A; Martín Del Valle F; González Salaices M; Prieto Jurczynska C; Carneado Ruiz J
    Neurologia; 2011 Jun; 26(5):285-90. PubMed ID: 21353345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic epilepsy with generalized seizures in early childhood].
    Gross-Selbeck G
    Monatsschr Kinderheilkd; 1992 Aug; 140(8):451-6. PubMed ID: 1435803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L; Buyse G; Ceulemans B
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
    Glauser T; Kluger G; Sachdeo R; Krauss G; Perdomo C; Arroyo S
    Neurology; 2008 May; 70(21):1950-8. PubMed ID: 18401024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P; Alving J; Gram L; Beck S
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study.
    Camfield P; Camfield C
    Epilepsia; 2007 Jun; 48(6):1128-32. PubMed ID: 17442010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levetiracetam in the treatment of epilepsy].
    Mariero Klees T; Brodtkorb E; Nakken KO; Lossius R; Johannessen SI
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1539-41. PubMed ID: 12822020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lennox-Gastaut syndrome in Spain: a descriptive retrospective epidemiological study].
    Herranz JL; Casas-Fernández C; Campistol J; Campos-Castelló J; Rufo-Campos M; Torres-Falcón A; de Rosendo J
    Rev Neurol; 2010 Jun; 50(12):711-7. PubMed ID: 20533249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.